Senti Biosciences News

Senti Biosciences | 10-K: Annual report

Mar 21 22:21 ET

Senti Biosciences | 8-K: Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights

Mar 21 16:19 ET

Senti Biosciences | 8-K: Current report

Feb 6 16:43 ET

Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Rajangam Kanya

Feb 2 17:33 ET

Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Lu Timothy K

Feb 2 17:31 ET

Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer KNOBELMAN DEBORAH

Feb 2 17:27 ET

Senti Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jan 10 00:00 ET

Senti Biosciences | 8-K: Current report

Jan 5 00:00 ET

Senti Biosciences | 8-K: Current report

Dec 22, 2023 06:34 ET

Senti Biosciences: Q3 2023 Earnings Report

Nov 13, 2023 19:11 ET

Senti Biosciences | 8-K: Senti Bio Announces Third Quarter 2023 Results and Pipeline Updates

Nov 13, 2023 16:29 ET

Senti Biosciences | 424B3: Prospectus

Nov 13, 2023 16:02 ET

Senti Biosciences | 424B3: Prospectus

Nov 13, 2023 16:01 ET

Senti Biosciences | 8-K: Current report

Nov 6, 2023 16:17 ET

Senti Biosciences | EFFECT: Others

Nov 6, 2023 00:15 ET

Senti Biosciences | EFFECT: Others

Nov 6, 2023 00:15 ET

Senti Biosciences | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Nov 1, 2023 17:26 ET

Senti Biosciences | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Nov 1, 2023 17:23 ET

Senti Biosciences | 424B3: Prospectus

Aug 11, 2023 08:56 ET

Senti Biosciences | 424B3: Prospectus

Aug 11, 2023 08:53 ET